Navigation Links
VivoMetrics(R) Appoints Howard R. Baker as New President and Chief Executive Officer
Date:12/12/2007

VENTURA, Calif., Dec. 12 /PRNewswire/ -- VivoMetrics Inc., a provider of leading edge non-invasive vital function monitoring, announced the appointment of Howard R. Baker to the position of president and chief executive officer. Mr. Baker succeeds Paul Kennedy, who will remain with the company in the role of executive vice president.

Mr. Baker joins VivoMetrics with over 28 years in leadership roles: developing global markets, commercializing products and services and helping pioneer adoption of innovative technologies. Prior to joining VivoMetrics, Mr. Baker served 10 years in senior management positions at Medtronic Corporation, the Fortune 500 global leader in medical device technologies, within the emergency response systems, cardiac surgery and diabetes businesses. Over the previous 11 years, he served in executive and senior leadership positions at Positron Corporation, a pioneer in positron emission tomography (PET) imaging technologies, and Fonar Corporation, an innovator and supplier of magnetic resonance imaging devices and services. Mr. Baker began his career in sales at leading health care companies including Space Labs, CR Bard and Abbott Labs.

"We are pleased to have someone with Howard's extensive background and proven track record take over the helm at VivoMetrics," commented John Erb, chairman of the VivoMetrics board of directors. Mr. Erb continued by saying, "Howard's leadership experience, along with demonstrated successes in developing and expanding market opportunities for technology, products and services, make him well-qualified to lead VivoMetrics towards its anticipated accelerated growth."

"VivoMetrics stands poised to take advantage of market development opportunities that have been cultivated over the past eight years, and I'm very excited to join the company at this time," said Mr. Baker. "VivoMetrics has developed technology and led the charge in changing how scientific research, clinical study and fitness assessment are conducted. I think the potential for our future success is unlimited."

About VivoMetrics

VivoMetrics, founded in 1999 and based in Ventura, Calif., provides non-invasive products and services, using its proprietary LifeShirt(R) technology, which continuously monitor vital, life-sign functions, such as heart rate, ECG, respiration rate, flow, and volume, posture, and activity. The company's offerings, based on patented, field-tested technologies, were initially focused on improving the speed, outcomes and economics of pharmaceutical research. Since its inception, the company has further expanded its offerings for use by military, first responder and biohazard personnel, as well as athletes and for clinical, academic and corporate research.


'/>"/>
SOURCE VivoMetrics
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
Breaking Biology News(10 mins):